Mari Wataya-Kaneda, Hiroshi Nagai, Yuuki Ohno, Hiroo Yokozeki, Yasuyuki Fujita, Hironori Niizeki, Kazue Yoshida, Masaaki Ogai, Yuichi Yoshida, Akihiko Asahina, et al. Safety and Efficacy of the Sirolimus Gel for TSC Patients With Facial Skin Lesions in a Long-Term, Open-Label, Extension, Uncontrolled Clinical Trial. Dermatology and therapy. 2020
H Nagai, C Nishigori. Image Gallery: Antihelix red-violaceous macules in juvenile dermatomyositis associated with antimelanoma differentiation-associated protein 5 antibody. The British journal of dermatology. 2020. 182. 3. e85
Makoto Nagai, Chiharu Tominaga, Sakaguchi Yoshiko, Hiroshi Nagai, Noriko Ohgo, Chikako Nishigori, Kiyofumi Yamanishi. A MILD CASE OF DOMINANT DYSTROPHIC EPIDERMOLYSIS BULLOSA DIAGNOSED BY NEXT-GENERATION SEQUENCING. JOURNAL OF DERMATOLOGY. 2014. 41. 59-59
Hiroshi Nagai, Chikako Nishigori. LICHEN PLANUS PIGMENTOSUS-INVERSUS MANIFESTING AS EXTENSIVE BUT SPONTANEOUSLY REGRESSING LESIONS. JOURNAL OF DERMATOLOGY. 2014. 41. 114-114
Rika Nishikawa, Hiroshi Nagai, Toshinori Bito, Mayumi Hatakeyama, Ayuko Kikusawa, Haruhisa Kanki, Yasuko Sarayama, Tetsuya Ikeda, Hitoshi Yoshizaki, Hidenobu Seto, et al. CLINICAL IMPLICATION OF NEUTRALIZING ANTIBODIES TO ADALIMUMAB AND INFLIXIMAB AND THEIR CONCENTRATION IN THE TREATMENT FOR PSORIASIS. JOURNAL OF DERMATOLOGY. 2014. 41. 12-12